Reduction in cytokines/chemokines in severe sepsis: Results from a phase li randomized placebo- controlled double blind trial of talactoferrin alfa in severe sepsis

Category Primary study
JournalAmerican Journal of Respiratory and Critical Care Medicine
Year 2011
This article has no abstract
Epistemonikos ID: 4bcb8740fbf128076d54ee6ca83a2bd8636e9977
First added on: Feb 05, 2025